Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Mullish

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Gastroenterology|March 25, 2026
Efimosfermin, a fibroblast growth factor 21 analogue, for metabolic dysfunction-associated steatohepatitisBenjamin H Mullish, Benjamin H Mullish
Gastroenterology|August 21, 2025
Exploring the differential impact of steatotic liver disease phenotypes upon clinical outcomesBenjamin H Mullish
Nature Reviews. Gastroenterology & Hepatology|March 18, 2026
Defining 'gut health': a leap forward, but still some road to travelBenjamin H Mullish
Gastroenterology|December 2, 2024
New Agonists of the Incretin/Glucagon System for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisBenjamin H Mullish
Gastroenterology|January 21, 2023
The Impact of Proportional Dietary Carbohydrate and Fat Content on Type 2 Diabetes and NAFLDBenjamin H Mullish
Gastroenterology|December 26, 2023
Pharmacotherapy in Managing Alcohol-Use DisorderBenjamin H Mullish
The New England Journal of Medicine|November 6, 2014
Case 25-2014: A man with ulcerative colitis and bloody diarrheaBenjamin H Mullish
Gastroenterology|April 16, 2023
Alcohol Minimum Unit Pricing Reduces Alcohol-Specific Hospitalizations and DeathsBenjamin H Mullish
Gastroenterology|September 26, 2023
Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?Benjamin H Mullish
Gastroenterology|June 10, 2022
Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver DiseaseBenjamin H Mullish
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Gastroenterology|March 25, 2026
Efimosfermin, a fibroblast growth factor 21 analogue, for metabolic dysfunction-associated steatohepatitisBenjamin H Mullish, Benjamin H Mullish
Gastroenterology|August 21, 2025
Exploring the differential impact of steatotic liver disease phenotypes upon clinical outcomesBenjamin H Mullish
Nature Reviews. Gastroenterology & Hepatology|March 18, 2026
Defining 'gut health': a leap forward, but still some road to travelBenjamin H Mullish
Gastroenterology|December 2, 2024
New Agonists of the Incretin/Glucagon System for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisBenjamin H Mullish
Gastroenterology|January 21, 2023
The Impact of Proportional Dietary Carbohydrate and Fat Content on Type 2 Diabetes and NAFLDBenjamin H Mullish
Gastroenterology|December 26, 2023
Pharmacotherapy in Managing Alcohol-Use DisorderBenjamin H Mullish
The New England Journal of Medicine|November 6, 2014
Case 25-2014: A man with ulcerative colitis and bloody diarrheaBenjamin H Mullish
Gastroenterology|April 16, 2023
Alcohol Minimum Unit Pricing Reduces Alcohol-Specific Hospitalizations and DeathsBenjamin H Mullish
Gastroenterology|September 26, 2023
Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?Benjamin H Mullish
Gastroenterology|June 10, 2022
Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver DiseaseBenjamin H Mullish
Pageof 15